genedrive (LON:GDR) Stock Price Down 3.3% – Should You Sell?

genedrive plc (LON:GDR) shares traded down 3.3% on Friday. The company traded as low as GBX 1.15 and last traded at GBX 1.16. 2,297,968 shares changed hands during mid-day trading, a decline of 59% from the average daily volume of 5,539,027 shares. The stock had previously closed at GBX 1.20.

genedrive Trading Down 3.3%

The company has a debt-to-equity ratio of -120.48, a quick ratio of 5.52 and a current ratio of 0.99. The company has a 50 day moving average of GBX 1.23 and a two-hundred day moving average of GBX 1.15. The stock has a market cap of £18.62 million, a PE ratio of -1.47 and a beta of 0.97.

Insider Activity

In related news, insider Gino Miele bought 700,000 shares of the business’s stock in a transaction dated Friday, August 28th. The stock was acquired at an average price of GBX 1 per share, with a total value of £7,000. 28.09% of the stock is currently owned by company insiders.

genedrive Company Profile

genedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.